Clinical Trials Logo

Clinical Trial Summary

Controversy exists in the treatment of airway hemangiomas ranging from tracheotomy, various lasers, to open removal, none of which have proven to be a gold standard. Venous malformations of the airway are difficult to treat and also require laser therapy or open removal and often repeated treatments are required. Similarly airway lymphatic malformations can require multiple treatment modalities as well as multiple procedures and are infrequently eradicated when extensive. New uses for various lasers and differing treatment protocols are frequently developed. Review of the treatment modalities and efficacy of these methods is required. The goal of this research is to determine protocols for treatment of airway vascular malformation and to evaluate our results from treatment of these lesions.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT00866827
Study type Observational
Source University of Arkansas
Contact
Status Completed
Phase
Start date December 2002
Completion date April 15, 2014

See also
  Status Clinical Trial Phase
Terminated NCT01212965 - Selenium in the Treatment of Complicated Lymphatic Malformations Phase 1
Completed NCT03427619 - OK432 (Picibanil) in the Treatment of Lymphatic Malformations Phase 2
Recruiting NCT05948943 - Alpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associated With a PIK3CA Mutation. Phase 2/Phase 3
Completed NCT02335242 - Sildenafil for the Treatment of Lymphatic Malformations Phase 2
Completed NCT00577213 - Diagnosis of Hemangiomas and Vascular Malformations N/A
Completed NCT00010452 - Study of Picibanil (OK432) Sclerotherapy in Children With Macrocystic Lymphatic Malformations Phase 2/Phase 3